Education
About Us
Working with TipRanks
Follow Us
Quanterix Corporation (QTRX)
NASDAQ:QTRX
Earnings Data
Report Date
Nov 05, 2025After Close (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.47Last Year’s EPS
-0.22Same Quarter Last Year
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call presented a mix of strategic achievements and significant challenges. The company highlighted strong strategic moves and synergies following the Akoya acquisition, a stable consumables revenue stream, and expansion into new market segments. However, these positives were overshadowed by considerable revenue declines, particularly in academic and pharma sales, alongside increased operating expenses and a significant drop in gross margin. The company's focus on long-term growth and cost savings offers a positive outlook, but current financial challenges are significant.Company Guidance
Akoya Acquisition Completed
Quanterix completed the transformative Akoya acquisition, aiming for long-term growth and value creation through synergy savings and a stronger market position.
Strategic Revenue Growth Drivers
Investments in strategic drivers to support sustainable double-digit revenue growth and margin improvement, positioning for breakeven in 2026.
Synergy Savings Achieved
Quanterix expects to achieve approximately $85 million in synergy savings and cost reductions, with 75% of these savings already implemented.
Expansion of Addressable Market
Quanterix expanded its addressable market to $5 billion across neurology, immunology, and oncology, with a strong consumables revenue of approximately $100 million.
Strong Consumables Revenue
Consumables revenue was stable, approximately $100 million pro forma, demonstrating resilience in a challenging macro environment.
Simoa Platform Expansion
Launch of Simoa One by the end of 2025, expanding the addressable installed base by 20x to over 20,000 systems globally, creating substantial high-margin growth opportunities.
Alzheimer's Diagnostic Franchise Progress
Doubled test volumes, tripled revenues, and expanded international regulatory footprint with new partnerships, on track for Medicare pricing recommendation.
QTRX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
QTRX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 07, 2025 | $5.51 | $4.75 | -13.79% |
May 12, 2025 | $5.73 | $4.64 | -19.02% |
Mar 17, 2025 | $7.28 | $7.15 | -1.79% |
Nov 12, 2024 | $15.17 | $12.40 | -18.26% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Quanterix Corporation (QTRX) report earnings?
Quanterix Corporation (QTRX) is schdueled to report earning on Nov 05, 2025, After Close (Confirmed).
What is Quanterix Corporation (QTRX) earnings time?
Quanterix Corporation (QTRX) earnings time is at Nov 05, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is QTRX EPS forecast?
QTRX EPS forecast for the fiscal quarter 2025 (Q3) is -0.47.